- Home
- ALDX vs MCR Comparison
ALDX vs MCR Comparison
Compare ALDX & MCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALDX
- MCR
- Stock Information
- Founded
- ALDX 2004
- MCR 1989
- Country
- ALDX United States
- MCR United States
- Employees
- ALDX N/A
- MCR N/A
- Industry
- ALDX Biotechnology: Pharmaceutical Preparations
- MCR Trusts Except Educational Religious and Charitable
- Sector
- ALDX Health Care
- MCR Finance
- Exchange
- ALDX Nasdaq
- MCR Nasdaq
- Market Cap
- ALDX 304.9M
- MCR 266.0M
- IPO Year
- ALDX 2014
- MCR N/A
- Fundamental
- Price
- ALDX $6.35
- MCR $6.28
- Analyst Decision
- ALDX Strong Buy
- MCR
- Analyst Count
- ALDX 2
- MCR 0
- Target Price
- ALDX $10.00
- MCR N/A
- AVG Volume (30 Days)
- ALDX 560.3K
- MCR 66.7K
- Earning Date
- ALDX 05-01-2025
- MCR 01-01-0001
- Dividend Yield
- ALDX N/A
- MCR 8.52%
- EPS Growth
- ALDX N/A
- MCR N/A
- EPS
- ALDX N/A
- MCR 0.38
- Revenue
- ALDX N/A
- MCR N/A
- Revenue This Year
- ALDX N/A
- MCR N/A
- Revenue Next Year
- ALDX N/A
- MCR N/A
- P/E Ratio
- ALDX N/A
- MCR $16.61
- Revenue Growth
- ALDX N/A
- MCR N/A
- 52 Week Low
- ALDX $2.71
- MCR $5.63
- 52 Week High
- ALDX $6.92
- MCR $6.70
- Technical
- Relative Strength Index (RSI)
- ALDX 55.70
- MCR 36.30
- Support Level
- ALDX $4.78
- MCR $6.36
- Resistance Level
- ALDX $6.52
- MCR $6.44
- Average True Range (ATR)
- ALDX 0.53
- MCR 0.05
- MACD
- ALDX -0.06
- MCR -0.02
- Stochastic Oscillator
- ALDX 73.36
- MCR 3.03
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. The company's product candidate, reproxalap, is a first-in-class treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer.
About MCR MFS Charter Income Trust
MFS Charter Income Trust is a United States-based closed-end fund. Its investment objective is to seek high current income. The fund invests the assets in debt instruments. It invests the assets in corporate bonds of U.S. and foreign issuers, U.S. Government securities, foreign government securities, mortgage-backed and other asset-backed securities of U.S. and foreign issuers, and debt instruments of issuers located in emerging market countries.